486 related articles for article (PubMed ID: 10914849)
41. Gastrointestinal health care resource use and costs associated with nonsteroidal antiinflammatory drugs versus acetaminophen: retrospective cohort study of an elderly population.
Rahme E; Joseph L; Kong SX; Watson DJ; LeLorier J
Arthritis Rheum; 2000 Apr; 43(4):917-24. PubMed ID: 10765939
[TBL] [Abstract][Full Text] [Related]
42. Persistence with non-selective NSAIDs and celecoxib among patients with gastroesophageal reflux disease and osteoarthritis or rheumatoid arthritis.
Cryer B; Luo X; Assaf AR; Sands G; Mardekian J
Curr Med Res Opin; 2011 Feb; 27(2):295-302. PubMed ID: 21142617
[TBL] [Abstract][Full Text] [Related]
43. Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritis.
Rabeneck L; Goldstein JL; Vu A; Mayne TJ; Rublee DA
Am J Gastroenterol; 2005 May; 100(5):1043-50. PubMed ID: 15842577
[TBL] [Abstract][Full Text] [Related]
44. Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy.
Wolfe F; Caplan L; Michaud K
Arthritis Rheum; 2006 Feb; 54(2):628-34. PubMed ID: 16447241
[TBL] [Abstract][Full Text] [Related]
45. COX-2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors.
van der Linden MW; Gaugris S; Kuipers EJ; van Herk-Sukel MP; van den Bemt BJ; Sen SS; Herings RM
Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):880-90. PubMed ID: 19593747
[TBL] [Abstract][Full Text] [Related]
46. Predictors of infection in rheumatoid arthritis.
Doran MF; Crowson CS; Pond GR; O'Fallon WM; Gabriel SE
Arthritis Rheum; 2002 Sep; 46(9):2294-300. PubMed ID: 12355476
[TBL] [Abstract][Full Text] [Related]
47. Prevalence of gastroprotective agent (GPA) use in adults with arthritis in the United States.
Coyne KS; Margolis MK; Cappelleri JC; Hsieh R; Essex MN; Park PW; Joshi AV
Curr Med Res Opin; 2013 May; 29(5):421-33. PubMed ID: 23444970
[TBL] [Abstract][Full Text] [Related]
48. Longer use of COX-2-specific inhibitors compared to nonspecific nonsteroidal antiinflammatory drugs: a longitudinal study of 3639 patients in community practice.
Wolfe F; Michaud K; Burke TA; Zhao SZ
J Rheumatol; 2004 Feb; 31(2):355-8. PubMed ID: 14760808
[TBL] [Abstract][Full Text] [Related]
49. A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use.
Lanas A; Perez-Aisa MA; Feu F; Ponce J; Saperas E; Santolaria S; Rodrigo L; Balanzo J; Bajador E; Almela P; Navarro JM; Carballo F; Castro M; Quintero E;
Am J Gastroenterol; 2005 Aug; 100(8):1685-93. PubMed ID: 16086703
[TBL] [Abstract][Full Text] [Related]
50. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs.
Ray WA; Chung CP; Stein CM; Smalley WE; Hall K; Arbogast PG; Griffin MR
Gastroenterology; 2007 Sep; 133(3):790-8. PubMed ID: 17854591
[TBL] [Abstract][Full Text] [Related]
51. NSAID-related upper gastrointestinal bleeding: are risk factors considered during prophylaxis?
Dincer D; Duman A; Dikici H; Arici C; Suleymanlar I; Isitan F
Int J Clin Pract; 2006 May; 60(5):546-8. PubMed ID: 16700851
[TBL] [Abstract][Full Text] [Related]
52. HZT-501 (DUEXIS(®); ibuprofen 800 mg/famotidine 26.6 mg) gastrointestinal protection in the treatment of the signs and symptoms of rheumatoid arthritis and osteoarthritis.
Schiff M; Peura D
Expert Rev Gastroenterol Hepatol; 2012 Feb; 6(1):25-35. PubMed ID: 22149579
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of small bowel injury in patients with rheumatoid arthritis by capsule endoscopy: effects of anti-rheumatoid arthritis drugs.
Sugimori S; Watanabe T; Tabuchi M; Kameda N; Machida H; Okazaki H; Tanigawa T; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Oshitani N; Koike T; Higuchi K; Arakawa T
Digestion; 2008; 78(4):208-13. PubMed ID: 19142000
[TBL] [Abstract][Full Text] [Related]
54. A cross-sectional retrospective assessment of anti-arthritic drugs in patients with arthritis in Korea.
Lee MC; Lee S; Suh DC; Kim J; Kong SX;
Curr Med Res Opin; 2003; 19(7):597-602. PubMed ID: 14606981
[TBL] [Abstract][Full Text] [Related]
55. Fatigue, rheumatoid arthritis, and anti-tumor necrosis factor therapy: an investigation in 24,831 patients.
Wolfe F; Michaud K
J Rheumatol; 2004 Nov; 31(11):2115-20. PubMed ID: 15517621
[TBL] [Abstract][Full Text] [Related]
56. Verification of a decision analytic model assumption using real-world practice data: implications for the cost effectiveness of cyclo-oxygenase 2 inhibitors (COX-2s).
Cox ER; Motheral B; Mager D
Am J Manag Care; 2003 Dec; 9(12):785-94. PubMed ID: 14712755
[TBL] [Abstract][Full Text] [Related]
57. Gender differences in NSAID use among older adults with osteoarthritis.
Dominick KL; Ahern FM; Gold CH; Heller DA
Ann Pharmacother; 2003 Nov; 37(11):1566-71. PubMed ID: 14565813
[TBL] [Abstract][Full Text] [Related]
58. The hidden cost of nonselective nonsteroidal antiinflammatory drugs in older patients.
Solomon DH; Glynn RJ; Bohn R; Levin R; Avorn J
J Rheumatol; 2003 Apr; 30(4):792-8. PubMed ID: 12672201
[TBL] [Abstract][Full Text] [Related]
59. Incidence of outpatient physician claims for upper gastrointestinal symptoms among new users of celecoxib, ibuprofen, and naproxen in an insured population in the United States.
Goldstein JL; Zhao SZ; Burke TA; Palmer R; von Allmen H; Henderson SC
Am J Gastroenterol; 2003 Dec; 98(12):2627-34. PubMed ID: 14687808
[TBL] [Abstract][Full Text] [Related]
60. Influence of Helicobacter pylori eradication therapy on the occurrence of gastrointestinal events in patients treated with conventional nonsteroidal antiinflammatory drugs combined with omeprazole.
Bannwarth B; Dorval E; Caekaert A; Barthelemy P
J Rheumatol; 2002 Sep; 29(9):1975-80. PubMed ID: 12233895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
